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Abstract
Background: Hemangiopericytoma occurs with increasing frequency in 5th decade of life and has
prediction for retroperitoneum and extremities. A case of a local recurrence and metastases of
hemangiopericytoma is described.
Case presentation: Recurrence of hemangiopericytoma in the greater omentum and the jejunal
mesentery as well as metastases in the retroperitoneal space were diagnosed in a 61-year-old
patient who had a hemangiopericytoma of the greater omentum excised 18 years before.
Conclusion: Because of the rarity of this disease and its typical clinical course associated with late
recurrence and metastases, the authors decided to present this case emphasizing the necessity of
systematic oncological follow-up after the end of treatment.
Background
Hemangiopericytoma is a tumor originating from the vas-
cular pericytes of Zimmermann. Most frequently it occurs
in patients aged 40 and above with its main localization
in the retroperitoneum, pelvis and lower extremities [1-3],
however, it may occur at any age in almost any part of
body [4]. One of the typical features of this tumor is that
both metastasis and recurrence could become apparent
even after several years in remission [5-7].
We report the case of a local recurrence and metastases in
the retroperitoneum infiltrating the liver and diaphragm
in a 61-year-old patient operated on due to a hemangi-
opericytoma of the greater omentum 18 years before.
Case presentation
A 61-year-old patient was admitted to the Department of
Transplantation and General Surgery with a tumor diag-
nosed in the left lumbar and retroperitoneal space. Eight-
een years before he had been operated for a tumor of the
greater omentum with histopathological diagnosis hae-
mangiopericytoma omenti maioris, until now with no
recurrence nor distant metastases were found.
On admission the patient was in good general condition
with left lumbar pain and a mobile tumor in this area.
Abdominal ultrasonography (US) and computed tomog-
raphy (CT) revealed a retroperitoneum space tumor with
suspected infiltration of the segment VII of the liver and
diaphragm.
Laboratory investigation showed no abnormalities. The
patient was qualified for surgical treatment. A tumor of 5
cm in diameter in the greater omentum tightly adjacent to
a transverse colon (figure 1), a tumor of 1 cm in diameter
in the jejunum mesentery (figure 2, arrow) and a tumor of
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12 cm in diameter located in the retroperitoneal space and
infiltrating the diaphragm and the segment VII of the liver
were found. No other lesions were found in intraoperative
US. The tumors of the greater omentum and of the jeju-
num mesentery were excised whereas the retroperitoneal
space tumor was removed en bloc with the infiltrated part
of the diaphragm and the segment VII of the liver (figure
3, and 4). The postoperative course proved uneventful.
The patient was discharged from the hospital 7 days after
the procedure in good general condition with a subse-
quent surgical follow-up recommended.
Histopathological examination of all the lesions showed
haemangiopericytoma malignum. The patient remains
under the Oncology Centre and our clinical follow-up
and at present, 3 months after the procedure, is in good
condition.
Discussion
Hemangiopericytomas represent less than 1% of all vascu-
lar neoplasms [8]. They are highly vascular, therefore
could be revealed by angio-CT and angiography (for diag-
nosis, tumor size, relationship to other viscera, source of
blood supply) as well as undergo preoperative transarte-
rial embolization if necessary [3,5]. The tumors' medium
size is 6.5 cm and they are encapsulated by a pseudocap-
sule [1,3]. There is no grading scale for hemangiopericy-
toma; its malignant potential is implied by histology and
clinical behavior [5]. Hypervascularity is a contraindica-
tion to a biopsy, therefore a histopathological diagnosis is
established after an excision of the lesion. Potentially
malignant tumors are characterized by 1 mitotic figure per
10 high-power field and moderate anaplasia. According to
McMaster et al., 25 of 32 (78%) malignant tumors, 6 of 16
(37.5%) borderline lesions and no benign tumors metas-
tasised [6].
Metastases occur by hematogenous and lymphogenous
routes affecting mainly the lung, liver, bones and regional
lymph nodes [1,3,9,10]. Metastasis to pleura have also
been reported [11]. Metastases occurring many years after
excision of a primary lesion is typical of hemangiopericy-
Retroperitoneal space tumor with the infiltrated part of the  diaphragm and the segment VII of the liver – postoperative  specimen Figure 3
Retroperitoneal space tumor with the infiltrated part of the 
diaphragm and the segment VII of the liver – postoperative 
specimen.
Tumor the greater omentum adjacent to a transverse colon  in situ Figure 1
Tumor the greater omentum adjacent to a transverse colon 
in situ.
Tumor of the jejunum mesentery (arrow) in situ Figure 2
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toma: In our case it was 18 years. Multiple hepatic and
bone metastases 12 years after an excision of a nose tumor
have been reported [12]. McMaster et al., reveal that
metastases became apparent in 11% of patients with
malignant tumors and 7% with borderline tumors after 5
years' remission [6]. Local recurrence is also common and
precedes metastases in more than 2/3 of cases [1,13]. In
two cases presented by Panda et al., it occurred after 4
months in one patient and 22 years in another [7]. There-
fore long-term follow-up is essential [6]. Hypercellularity,
mitotic activity, anaplasia, necrosis and hemorrhage are
reported to be associated with higher malignant potential
[13].
Surgical resection with subsequent radiotherapy remains
the treatment of choice for hemangiopericytoma. The role
of preoperative angiography and tumor embolization is
also emphasized in literature [3,5,6]. Survival rates vary:
In a review of 106 cases of hemangiopericytoma, Enzinger
et al., reported 70% 10-year survival, whereas it was 50%
5-year survival according to other authors [1,10].
Late recurrence is common in other malignancies as well.
According to Shen et al., in primary cutaneous melanoma
the mean disease-free interval after surgery was 182
months [14] whereas Briele et al., report seven patients in
whom local or regional recurrence occured 11 to 23 years
after first treatment of melanoma [15]. Another neoplasm
after a treatment of which long-term follow-up is essential
is medulloblastoma as recurrences after the Collins' risk
period (i.e. age of a patient plus 9 months) have been
noticed [16,17]. The average follow-up in case of rectal
cancer surgical treatment is 2 years whereas research
shows that local recurrence can become evident even after
5.8 years and systemic recurrence after 7.9 years [18].
Continued long-term follow-up in patients treated for
above mentioned malignancies proves beneficial
[15,17,19].
Conclusion
Every patient treated due to a malignant or borderline
hemangiopericytoma should be under long-term onco-
logical follow-up as the risk of recurrence and distant
metastases even after many years is very high.
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